María Belén Tardivo

Improvement of in vitro stability and pharmacokinetics of hIFN-α by fusing the carboxyl-terminal peptide of hCG β-subunit.

M. Etcheverrigaray, R. Kratje, M. Oggero, 2016, Journal of biotechnology.

Physicochemical Characterization of a Recombinant eCG and Comparative Studies with PMSG Commercial Preparations

C. Prieto, N. Ceaglio, M. C. Rodríguez, 2023, The Protein Journal.

Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein

C. Prieto, Agustina Gugliotta, Victoria Gastaldi, 2022, Applied Microbiology and Biotechnology.

Production of Therapeutic Enzymes by Lentivirus Transgenesis.

C. Prieto, M. Etcheverrigaray, N. Ceaglio, 2019, Advances in experimental medicine and biology.

High yield process for the production of active human α‐galactosidase a in CHO‐K1 cells through lentivirus transgenesis

C. Prieto, M. Etcheverrigaray, N. Ceaglio, 2017, Biotechnology progress.

Development of a suitable manufacturing process for production of a bioactive recombinant equine chorionic gonadotropin (reCG) in CHO-K1 cells.

C. Prieto, H. Ortega, G. Bó, 2021, Theriogenology.

A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes

C. Prieto, J. Cassataro, Agustina Gugliotta, 2023, Applied Microbiology and Biotechnology.